CrelioHealth vs Flabs
Cloud-Native Diagnostics Suite vs. Feature-Rich Indian LIS: which fits your lab?
CrelioHealth and Flabs both serve Indian diagnostic labs, and both have meaningful functionality for clinical laboratory operations. Flabs has built a solid reputation among independent diagnostic labs and small diagnostic chains across India, offering a feature-rich LIS with a focus on practical, affordable lab management. CrelioHealth brings a cloud-native architecture, AI-driven lab operations, a full product suite covering LIMS, Cloud PACS/RIS, Inventory, and Patient Engagement, and continuous software delivery. This guide gives you an honest, side-by-side view so your evaluation team can choose the right platform for your lab's scale, ambitions, and budget.
Quick Comparison: CrelioHealth vs Flabs
A high-level snapshot across the criteria that matter most to Indian lab directors, IT heads, and procurement teams evaluating both platforms.
Flabs is a reliable and cost-effective platform that works well for independent diagnostic labs in India looking for a practical, locally-supported LIS without the complexity of a full cloud-native suite. If your lab has a stable single-location workflow, a limited IT budget, and does not need radiology, AI-driven operations, or multi-branch scaling in the near term, Flabs is a legitimate option worth evaluating on its own terms.
Pricing Models Compared
Both platforms are priced competitively for the Indian market. The total cost difference becomes most visible when accounting for infrastructure, upgrade cycles, and the cost of running multiple modules across branches.
Neither platform publishes a standard public rate card. Request itemised quotes from both vendors covering implementation, training, annual subscription, and any per-branch or per-module pricing before comparing totals.
AI Capabilities: CrelioHealth vs Flabs
CrelioHealth’s AI is built into daily lab operations. Flabs focuses on practical reporting and workflow management without a dedicated AI layer.
Where Both Platforms Align
Despite different deployment models and scale targets, CrelioHealth and Flabs share meaningful common ground in core LIS functionality, Indian compliance workflows, and essential integrations for Indian diagnostic labs.
Which Platform Fits Your Lab?
An honest breakdown of which labs get the most value from each platform, based on lab type, growth stage, and operational priorities in the Indian diagnostics market.
Choose CrelioHealth if your lab…
- ✓Is scaling from a single location to a multi-branch diagnostic chain
- ✓Needs cloud-native operations with no on-premises server or IT overhead
- ✓Requires WhatsApp report delivery and a patient-facing portal natively, not as a workaround
- ✓Needs AI-driven TAT prediction, QC anomaly detection, and operational analytics summaries
- ✓Is adding radiology and needs Cloud PACS/RIS alongside LIMS in one platform
- ✓Has collection centres and needs real-time centralised reporting across India
- ✓Requires a dedicated reagent and inventory management module
- ✓Needs NABL, NABH, and international compliance including HIPAA or GDPR
- ✓Wants continuous cloud updates without IT coordination or version upgrade cycles
- ✓Is processing 500 or more tests per day and growing
Choose Flabs if your lab…
- ✓Is a stable, single-location independent diagnostic lab with no near-term expansion plans
- ✓Prefers an affordable, locally-supported platform with familiar on-premise or hosted deployment
- ✓Has an existing IT setup and is comfortable managing or coordinating upgrades
- ✓Needs core Indian lab compliance — NABL, NABH, GST billing, TPA workflows — at a lower entry cost
- ✓Does not require radiology or a dedicated inventory management module
- ✓Values a platform well-known among Indian independent labs with a local support team
- ✓Is primarily running standard pathology tests without complex AI or analytics requirements
CrelioHealth is the stronger choice for Indian diagnostic labs that are growing, digitising, or managing multi-branch operations and need a cloud-native platform with AI-driven lab ops, patient engagement, and a full product suite. Flabs is a sensible, cost-effective choice for stable independent labs that need reliable core LIS functionality, strong Indian compliance coverage, and local support, without the complexity or cost of a full cloud suite.
A Modern, Cloud-native Platform Built for Labs That Are growing
CrelioHealth is a cloud-native LIMS and full diagnostics suite designed for Indian clinical labs, diagnostic chains, collection centre networks, and radiology practices. Flabs is a well-established Indian LIS with strong practical functionality for independent labs, known for affordability and ease of use. CrelioHealth's differentiation comes from its architecture and scope: no on-premise servers, AI built into daily lab operations, a full suite including Cloud PACS/RIS and Inventory under one subscription, and continuous software delivery that keeps every lab on the latest version automatically. For labs that are digitising, scaling to multiple branches, or adding radiology alongside pathology, CrelioHealth is built for that growth trajectory.
True Cloud Architecture
No on-premise servers, no IT team needed. Access your LIS from any device anywhere in India, with real-time sync across all branches and collection centres.
Go Live in 2 to 6 Weeks
2–6 week implementation with pre-built templates for 15+ lab modalities and a dedicated onboarding specialist.
AI Built into Lab Operations
AI TRF Scan digitises paper test request forms. TAT prediction, QC anomaly detection, and operational analytics summaries are built into daily workflows.
NABL, NABH, and International Compliance
NABL ISO 15189, NABH, HIPAA, and GDPR natively supported — no separate compliance configuration project required.
Patient-First Engagement
WhatsApp report delivery, branded patient portal, online test booking, and phlebotomist dispatch app built into the platform.
Deep Integrations for Indian Labs
HL7, FHIR, bidirectional analyzer interfaces with all major Indian and international brands, HIS, TPA, and GST-compliant billing.
Common Questions About CrelioHealth vs Flabs
The answer depends on your lab's stage and needs. CrelioHealth is better suited for labs that are scaling, adding branches, launching home collection, or need cloud-native operations with AI analytics. Flabs suits stable independent labs that want a reliable, affordable, locally supported LIS for core pathology workflows without a large IT investment. Both are legitimate platforms for Indian diagnostic labs. The right choice depends on where your lab is heading, not just where it is today.
Yes. CrelioHealth supports NABL ISO 15189 and NABH workflows natively, including audit trails, QC documentation with Westgard rules, corrective action records, proficiency testing tracking, and chain-of-custody logs. Both accreditation frameworks are covered without a separate compliance configuration project or additional module. The audit trail is immutable and accessible for inspection at any time.
WhatsApp report delivery is a native, built-in feature of CrelioHealth, not a workaround or third-party integration. Patients receive their reports directly to WhatsApp automatically once results are validated and dispatched. This also works alongside SMS, email, and the branded patient portal. Flabs also supports WhatsApp delivery, so both platforms cover this India-specific requirement.
CrelioHealth typically achieves go-live in 2 to 6 weeks for most Indian diagnostic labs, with a dedicated implementation specialist managing configuration, data migration, and training. Flabs implementation timelines are similar for smaller labs but vary by lab size and configuration depth. The key difference is that CrelioHealth's cloud delivery eliminates server setup and IT infrastructure time entirely, which can significantly compress the timeline for labs moving from on-premises systems.
Yes, and this is one of CrelioHealth's strongest use cases in India. A single cloud instance manages multiple branches, collection centres, and reference lab partners in real time, with centralised reporting, branch-level test menus, consolidated GST billing, phlebotomist dispatch, and unified patient records. Flabs supports multi-location setups, but centralised real-time analytics and chain-wide operational visibility are more limited in the standard offering.
Yes. AI TRF Scan is a CrelioHealth-native feature that digitises handwritten and printed paper test request forms automatically at the point of registration. It reads the form, extracts patient and test data, and feeds it directly into the LIMS, eliminating manual transcription errors. This is particularly relevant for Indian labs that still receive paper TRFs from referral doctors or collection centres. Flabs does not currently offer this capability.
Flabs is a practical and cost-effective option for smaller Indian independent labs with stable volumes and tight budgets. If your lab is running standard pathology tests, does not need radiology, has a small branch footprint, and values local support and lower entry cost, Flabs is worth evaluating on its own terms. CrelioHealth's pricing is competitive, but its value is most evident at scale. For a lab that is just starting or not yet planning to expand, Flabs may offer a more proportionate solution for the current stage.
See how CrelioHealth fits your lab, live.
Book a 30-minute demo with a CrelioHealth India implementation specialist. Bring your modalities, your branch setup, and your accreditation questions.